Montelukast as a treatment for refractory cutaneous lupus: A case series.

Francisco Airton Castro RochaGuilherme Ferreira Maciel da SilvaIgor Albuquerque NogueiraRodolfo de Melo NunesConceição da Silva Martins

Published in: International journal of rheumatic diseases (2023)

This is the first report of a fast and sustained successful response of cutaneous lupus to MLK. Given its acceptable safety profile, our data encourage development of a randomized trial as an attempt to reposition MLK as a safe, affordable alternative to treat cutaneous lupus.

Keyphrases

systemic lupus erythematosus
disease activity
rheumatoid arthritis
electronic health record
big data
replacement therapy